- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Steven Adelsheim Discusses the Importance of Early Diagnosis for Young People With Psychosis
Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine, outlined the concept of duration of untreated psychosis, which connects time to treatment with outcomes, particularly in young people with psychosis.
Steven Adelsheim, MD, clinical professor of psychiatry and behavioral sciences, Stanford University School of Medicine, outlined the concept of duration of untreated psychosis, which connects time to treatment with outcomes, particularly in young people with psychosis.
Transcript
Why is early recognition and intervention for young people with psychosis so important?
Well, we know that the data really points that recognizing people early is critical in terms of their long-term outcome. We have this concept, duration of untreated psychosis, which really tells us that the shorter the time is from when someone develops full-blown psychotic symptoms to when they get treatment, the better they do in terms of school, work, adulthood in general 10, 15, 20 years later. So more and more, we recognize that early recognition and early treatment can have a huge and lifelong impact for our young people.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
